Two-Stage Revision Protocol in Multidrug Resistant Periprosthetic Infection Following Total Hip Arthroplasty Using a

George C Babis1, Vasileios I Sakellariou2, Panayiotis G Pantos3

  • 12nd Orthopaedic Department, University of Athens Medical School, Konstantopouleio General Hospital Nea Ionia, Athens, Greece.

Insights

This study found a prolonged two-stage revision protocol effective for treating hip periprosthetic joint infections, even with multidrug-resistant bacteria. The approach demonstrated safety and reproducibility in patient outcomes.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Biomedical Engineering

Background:

  • Periprosthetic hip infections pose significant challenges in revision arthroplasty.
  • Effective management strategies are crucial for limb salvage and patient quality of life.

Purpose of the Study:

  • To evaluate the efficacy and safety of a two-stage revision protocol for hip periprosthetic joint infections.
  • To assess the impact of a prolonged interim period on treatment outcomes.

Main Methods:

  • Retrospective review of medical records for 31 patients with hip periprosthetic joint infections.
  • Analysis of a two-stage revision protocol with a prolonged interim period (mean 9.2 months).
  • Evaluation of clinical outcomes using the Harris Hip Score.

Main Results:

  • A low rate of infection relapse (9.6%) required repeating the first stage.
  • Five cases of spacer dislocation occurred but did not impact final reimplantation outcomes.
  • No instances of hip protrusion or additional acetabular bone loss were observed.

Conclusions:

  • The prolonged two-stage revision protocol is a safe, simple, and effective treatment for hip periprosthetic joint infections.
  • This approach is particularly beneficial when managing infections caused by multidrug-resistant pathogens.
  • The protocol demonstrates reproducibility and positive clinical outcomes post-reimplantation.